Loading chat...
NY A05099
Bill
Status
2/12/2025
Primary Sponsor
Steve Stern
Click for details
AI Summary
-
Adds xylazine (N-(2,6-dimethylphenyl)-5,6-dihydro-4H-1,3-thiazin-2-amine) to Schedule I controlled substances as a depressant under New York's public health law
-
Exempts xylazine products approved by the FDA specifically for veterinary use, including injections for cattle and other nonhuman species
-
Imposes controlled substance penalties on anyone who knowingly administers, prescribes, dispenses, or distributes xylazine intended for human consumption or non-veterinary purposes
-
Takes effect 30 days after becoming law
Legislative Description
Adds xylazine to the depressants designated as controlled substances with the exception of use in cattle or other nonhuman species if approved by the federal food and drug administration.
Last Action
referred to health
1/7/2026